Mild asthma: from paradoxes to therapy optimization
https://doi.org/10.21518/2079-701X-2018-15-38-42
Abstract
Exacerbations of bronchial asthma are specific not only for severe, but also for mild disease course. Analysis of the causes revealed paradoxes in the treatment that contribute to the uncontrolled course of mild asthma. A promising direction is the use of combination drugs containing a early-onset beta-2-agonist and inhaled glucocorticosteroid, which can significantly improve adherence to treatment and significantly improve control and reduce the number of exacerbations. The review discusses in detail the merits of the combination drug SabaComb, its place in the recommendations for the treatment of mild asthma.
About the Author
R. S. Fassakhov
Institute of Fundamental Medicine and Biology; Kazan (Volga Region) Federal University
Russian Federation
Russian Federation
References
1. Nunes C et al. Asthma costs and social impact. Asthma Res Pract, 2017, 3: 1.
2. Chastek B et al. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. J Manag Care Spec Pharm, 2016, 22(7): 848-861.
3. Global Initiative for Asthma. 2018 GINA Report, Global Strategy for Asthma Management and Prevention.
4. Rabe KF, Vermeire PA, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) stud. Eur Respir J, 2000, 16: 802–807.
5. Sadatsafavi M, Lynd L, Marra C et al. Direct health care costs associated with asthma in British Columbia. Can Respir J, 2010, 17(2): 74–80.
6. Com-Ruelle L, Crestin B, Dumesnil SL. Asthmeen France selon les stades. La Lettre du Pneumologue, 2000, III(5): 191–193.
7. Nenasheva NM, Buriev BB. Features of atopic asthma in adults. Rossiyskiy Allergologicheskiy Zhurnal, 2009, 4: 12–17.
8. Arkhipov VV, Grigorieva EV, Gavrishina EV. Asthma control in Russia: results of the multicenter observational NIKA study. Pulmonologiya, 2011, 6: 80–86
9. Robertson CF, Rubinfield AR, Bowes G. Pediatriccasthmadeaths in Victoria: the mild are at risk. Pediatr Pulmonol, 1992, 13(2): 95–100.
10. Salmeron S, Liard R, Elkharrat D, Muir J, Neukirch F, Ellrodt A. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet, 2001, 358: 629–635.
11. Mitchell I, Tough SC, SempleLK,Green FH, Hessel PA. Near-fatal asthma:a populationbased study of riskfactors. Chest, 2002, 121: 1407–1413.
12. Why Asthma still kills. The National Review of Asthma Deaths. 2014. www.rcpiondon.ac.uk.
13. Yang JF et al. Insights into frequent asthma exacerbations from a primarycare perspective and the implications of UK National Review of Asthma Deaths recommendations. NPJ Primary Care Respiratory Medicine, 2018, 28: 35.
14. Boushey HA, Sorkness CA, King TS et al. Daily versus As-Needed Corticosteroids for Mild Persistent Asthma. N Engl J Med, 2005, 352: 1519–1528.
15. O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J, 2017, 50: 1701103.
16. World Health Organization. Adherence to longterm therapies: Evidence for action. Geneva, WHO, 2003.
17. Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol, 2004, 114: 1288–1293.
18. Laforest L, Licaj I, Devouassoux G et al. Prescribed therapy for asthma: therapeutic ratios and outcomes. BMC Fam Pract, 2015, 16: 49.
19. Papi A, Canonica GW, Maestrelli P et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med, 2007, 356(20): 2040–2052.
20. Fredenburgh L, Campion E, Drazen JM. Mild Persistent Asthma – Polling Results. N Engl J Med, 2007, 357: 179–180.
21. Martinez FD, Chinchilli VM, Morgan WJ et al Use of beclomethasone dipropionate as rescue treatment for childrenwith mild persistent asthma (TREXA): a randomised, doubleblind,placebo-controlled trial. Lancet, 2011, 377: 650-657.
22. Avdeev SN, et al. Principles of choice of therapy for patients with mild bronchial asthma. Concerted guidelines of Russian Association of Allergologists and Clinical Immunologists and Russian Respiratory Society. Prakticheskaya Pulmonologiya, 2017, 1: 82-92.
Review
For citations:
Fassakhov RS. Mild asthma: from paradoxes to therapy optimization. Meditsinskiy sovet = Medical Council. 2018;(15):38-42. (In Russ.) https://doi.org/10.21518/2079-701X-2018-15-38-42
Views:
902
Email this article 